Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child. To continue the gains made over the past 80 years, transformative changes with broad impact are needed in management of congenital heart disease. Three-dimensional printing is an emerging technology that is fundamentally affecting patient care, research, trainee education, and interactions among medical teams, patients, and caregivers. This paper first reviews key clinical cases where the technology has affected patient care. It then discusses 3-dimensional printing in trainee education. Thereafter, the role of this technology in communication with multidisciplinary teams, patients, and caregivers is described. Finally, the paper reviews translational technologies on the horizon that promise to take this nascent field even further.
. Use within cardiology has followed a similar trend, with growth mainly in the past decade (3). Vukicevic et al. (4) recently published an excellent review of cardiac 3D printing focusing primarily on acquired structural heart disease. In this paper, we review the transformative role of 3D printing in congenital heart disease (CHD) (Central Illustration).
SCOPE OF CONGENITAL HEART DISEASE AND THE NEED FOR TRANSFORMATIVE CARE
The prevalence of CHD is approximately 9 in 1,000 live births (5, 6) . Survival rates vary by disease complexity, with long-term survival (>20 years) at approximately 95% for simple CHD, 90% for moderate complexity, and 80% for severe, complex CHD (7).
Overall survival rates have steadily increased for even the most complex CHD (8) (9) (10) (11) , although survival alone is not a sufficient outcome measure in the current era.
Other important metrics include the following: longterm morbidity; reintervention rates; length of hospitalization; neurodevelopmental outcomes; cost to the health care system; and patient or caregiver satisfaction. Obtaining the best outcomes requires an impact at multiple levels, including patients and caregivers, individual clinicians, the medical team and the health care system. 3D printing is a disruptive technology that is affecting each of these key areas in CHD.
The earliest papers on cardiovascular 3D printing were published in the early 2000s. Binder et al. (12) showed feasibility from echocardiographic data in 2000, and Pentacost et al. (13) produced 3D models replicating cardiac embryology from photomicrographic data in 2001. Soon thereafter, datasets from computed tomography (CT) or magnetic resonance imaging (MRI) were used to produce 3D cardiac models of increasing complexity (14) (15) (16) , with a steady rise in publications in the past decade (3) . Figure 1 shows the applications of 3D printing in medicine, broadly categorized as surgical planning, education, and manufacturing of custom parts (17) .
Given that a 3D model is a replica of a patient's anatomy, models may be used for precise pre-surgical planning and simulation (18) (19) (20) (21) . Patient-specific presurgical planning may potentially reduce time spent in the operating room (OR) and result in fewer complications. In turn, this may lead to shorter postoperative stays, decreased reintervention rates, and lower health care costs. Given the relatively recent use of 3D printing in CHD, there are currently no data supporting these presumed outcomes. Most of the evidence in published reports is qualitative, through case reports and series. Emerging reports from other surgical subspecialties appear promising. Recent data from craniofacial reports suggest that 3D printing can improve outcomes, including saving time in the OR and thus translating to direct cost savings (22, 23) .
3D PRINTING TECHNOLOGY AND OPTIONS FOR CARDIOVASCULAR PRINTING
Several recent publications have described the process of medical 3D printing (3, 4, (24) (25) (26) (27) , summarized as these key steps:
1. Acquisition of a high-resolution 3D imaging dataset 2. Segmentation of the anatomy using specialized post-processing software 3. Computer-aided design to refine the design, add A subtype of the hollow models consists of intact hollow models. These models also show the intracardiac anatomy but are printed intact (i.e., without a cut-plane), thereby resulting in the most accurate representation of the heart as it sits in the chest.
When printed in a flexible material, these models allow cardiothoracic surgeons to use standard surgical approaches and see the anatomy from a "surgeon's perspective," as they would for the actual case ( Figures 5A and 5B) . Thus, these models are ideal for surgical simulation, especially when they are printed in materials that can be cut, can hold suture, 
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APPLICATIONS OF 3D PRINTING IN CHD
Several publications have described the use of 3D printing in CHD, spanning the spectrum from atrial or ventricular septal defects (ASDs, VSDs) (29, 30) to the most complex cardiac lesions (18, 21, 25, (31) (32) (33) (34) (35) (36) Anwar et al. a second flexible intact-heart model (no cut-plane) for surgical simulation. The internal anatomy of both models was identical. By using the models, detailed pre-surgical planning was performed. Specifically, the models were used to plan placement of the Fontan conduit (intracardiac or extracardiac) and to evaluate its relationship with systemic veins and impact on pulmonary veins. The model was also used to simulate "plan A," "plan B," or "bailout" scenarios, each with a unique surgical plan. This level of detailed surgical simulation is not feasible with current standard of care (e.g., 3D volumetric rendering), and it shows the added value of 3D printed models.
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Supplemental Video 1 ( Figure 7) shows the presurgical planning session for this case with the cardiothoracic surgeon and cardiologists. Anwar et al. Figure 8D ) and, ultimately, successful unifocalization ( Figure 8E ). 3D printing for pulmonary atresia and MAPCAs offers significant benefits over The dashed line indicates the potential ventricular septal defect (VSD) baffle pathway to achieve a 2-ventricle repair. Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle; RV ¼ right ventricle; SVC ¼ superior vena cava; other abbreviations as in Figure 5 . IVC ¼ inferior vena cava; RA ¼ right atrium.
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VENTRICULAR ASSIST DEVICE AND HEART TRANSPLANT.
An endpoint of many patients with CHD is heart failure requiring a ventricular assist device or heart transplant. 3D printing can aid in ventricular assist Anwar et al. SVC ¼ superior vena cava. Given the patient's debilitated state and multiple prior sternotomies, he was deemed a very high Anwar et al. (20, 25, 26, 68, 69) .
Representative cases are shown in Figures 13A to 13D , as previously described (68) .
ACCURACY AND QUALITY ASSURANCE IN CARDIAC 3D PRINTING
Accuracy in medical 3D printing is of paramount importance, although published reports on this topic are limited. Accuracy is defined by comparison with a gold standard, and in the case of 3D printed models, 1 metric of accuracy is comparison with operative findings. At our institution, the quality assurance process is driven by feedback from our surgical
Anwar et al.
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3D Printing in Congenital Heart Disease
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 2 , 2 0 1 8

3D Printing in Congenital Heart Disease
A P R I L 2 0 1 8 : 2 9 4 -3 1 2
FIGURE 11 Bioresorbable Airway Splint Manufactured From Polycaprolactone With a Bellowed Design to Promote Expansion and Growth Over Time
Reproduced with permission from Morrison et al. (48) . Image on the left shows a stent within main pulmonary artery (MPA). Image on the right is an angiogram taken after successful transcatheter implantation of pulmonary valve. PA ¼ pulmonary artery; TOF ¼ tetralogy of Fallot. Anwar et al.
Surgical Training course using 3D models. The majority of cardiothoracic surgeons reported that the 3D models were of "excellent" or "good" quality for surgical simulation (72) . .
In addition to allowing practice on highly accurate simulators, the 3D models expose trainees to pathological features they may rarely encounter. This shifts the practice of surgery from an "opportunity-based" (26) to a "curriculum-based" experience. For experienced practitioners, models may be used for lifelong learning, for maintenance of certification, or for practice before challenging cases. Thus, a repository of 3D printed cardiovascular models with the spectrum of CHD would be an ideal educational resource (82, 83) .
The 3D print Heart Library at the National Institutes of
Health (84) Anwar et al.
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A P R I L 2 0 1 8 : 2 9 4 -3 1 2 and physiology. Currently there are highly accurate noninvasive methods to assess cardiac function and blood flow (102), including methods to assess 3D information over the cardiac cycle, thereby providing "4D" function and flow. These multivariate datasets could be integrated into 3D models to build holistic models to advance our understanding of cardiac disease. As 3D models achieve more realistic states, they may be used to study pathophysiology, predict longterm outcomes, and choose optimal treatment plans or surgical repairs (58, (103) (104) (105) (106) (107) . Recent studies have analyzed blood flow in deformable models (108, 109) , including flow characteristics in patients with hypoplastic left heart syndrome following Norwood arch reconstruction (75, 110) .
Finally, bioprinting offers the potential to make the leap from printing "life-like" to living tissue itself.
This revolutionary technology is in its infancy; however, several techniques now exist that can deposit bioinks in precise locations to build up complex tissue constructs (111) . Bioprinting has been applied to print anatomically shaped cartilage structures (112), skin (113, 114) , implants for bone growth (115) , and even a 
